Skip to content
Retina & Vitreous

Lens-induced uveitis (phacoanaphylactic endophthalmitis)

Lens-induced uveitis (LIU) is a granulomatous uveitis caused by exposure of lens proteins, which normally have immune privilege, into the eye. It is also called “phacoanaphylactic endophthalmitis.” It was first reported by Verhoeff and Lemoine in 1919.

The frequency among all uveitis cases is extremely rare, less than 1% 1, 2); in one systematic review, only 6 out of 140 cases were clinically diagnosed. 1) With advances in modern cataract surgery techniques, the incidence is further decreasing.

This disease is broadly classified into the following two types based on the mechanism of onset. 1)

Phacogenic (Type IV)

Also known as: phacoantigenic uveitis

Mechanism: Rupture of the lens capsule leads to massive exposure of lens proteins into the anterior chamber, triggering a type IV (cell-mediated, delayed-type) hypersensitivity reaction.

Causes: Mainly due to capsule damage from trauma or surgery.

Phacolytic

Also known as: phacolytic uveitis / glaucoma

Mechanism: Proteins from a hypermature cataract leak through an intact capsule. Macrophages phagocytose the proteins and obstruct the trabecular meshwork.

Causes: Natural course of hypermature cataract.

Q Is lens-induced uveitis the same as infectious endophthalmitis?
A

They are different diseases. Infectious endophthalmitis is a purulent inflammation caused by pathogenic microorganisms such as bacteria or fungi, whereas LIU is a sterile granulomatous inflammation due to an immune reaction to lens proteins. However, their clinical presentations can be similar, requiring differentiation. See the Diagnosis and Testing section for details.

Onset is often acute to subacute, with symptoms occurring only in the affected eye.

  • Vision loss: May be severely reduced to hand motion or light perception. 1, 2)
  • Eye pain: Moderate to severe pain. 1, 2)
  • Redness: Mixed injection (ciliary injection + conjunctival injection) is observed.
  • Photophobia and tearing: Occur due to inflammation.

Slit-lamp microscopy findings are fundamental for diagnosis.

  • Elevated intraocular pressure: Marked elevation is often observed. Lopez-Zuniga et al. reported IOP of 15 mmHg1), and Bievel-Radulescu et al. described a case reaching IOP of 50 mmHg.2)
  • Anterior chamber fibrin: Observed in severe inflammation.1)
  • Pseudohypopyon: A white layered deposit at the bottom of the anterior chamber.2) It is composed of macrophages and lens proteins.
  • Keratatic precipitates (KP): Granulomatous inflammation may present with mutton-fat KP.
  • Retrolental opacity: The lesion may extend into the vitreous cavity.1)
Q Does pseudohypopyon look the same as hypopyon in infectious endophthalmitis?
A

Both appear as white deposits at the bottom of the anterior chamber and can be difficult to differentiate by slit-lamp alone. LIU pseudohypopyon originates from macrophages and lens proteins, and confirmation of sterility via aqueous humor culture is key for differentiation.

Breakdown of Immune Privilege of Lens Proteins

Section titled “Breakdown of Immune Privilege of Lens Proteins”

The lens is an immunologically privileged organ developmentally, and lens proteins are not recognized as “self” by the immune system.2) Normally, the lens capsule acts as a barrier, preventing an immune response. LIU occurs when this barrier is disrupted.

  • Hypermature cataract (Morgagnian cataract): The capsule weakens, leading to spontaneous rupture or protein leakage. 2) Late-stage cataracts are common especially in areas with limited access to medical care, and are a major cause of LIU.
  • Ocular trauma: Capsular damage due to blunt or penetrating injury.
  • Complications during cataract surgery: Capsular rupture or retained cortical material.
  • Long-standing untreated cataract: Liquefaction of the lens cortex and increased capsular permeability.

Clinical diagnosis of LIU is not easy; in one report, only 6 out of 140 observed cases were clinically diagnosed. 1)

  1. History taking: Confirm the duration of untreated cataract, history of ocular trauma, and past ocular surgeries.
  2. Slit-lamp examination: Assess anterior chamber inflammation, keratic precipitates (KP), and presence of pseudohypopyon.
  3. UBM (Ultrasound Biomicroscopy): Evaluate for lens capsule defects, aiding in disease classification and surgical planning. 1)
  4. Intraocular pressure measurement: Check for elevated IOP due to trabecular meshwork obstruction.
  5. Aqueous humor needle biopsy (definitive diagnosis): If zonal granuloma is observed, it confirms the diagnosis. 2)

Differential diagnosis from the following diseases is particularly important. 1, 2)

Differential DiseaseKey Points for Differentiation
Infectious EndophthalmitisCulture positive, rapid progression
TASSImmediately after surgery, sterile
Sympathetic OphthalmiaInflammation also in the fellow eye
Q Should LIU be suspected if the eye becomes red and painful after cataract surgery?
A

If it occurs immediately after surgery, postoperative endophthalmitis or TASS is also possible. On the other hand, if symptoms develop long after surgery, or if there is a history of hypermature cataract or ocular trauma, LIU should be suspected. UBM and aqueous humor analysis help in differentiation.

Cataract surgery (lens extraction) is the only curative treatment. 2) Glaucoma surgery alone, such as trabeculectomy, is ineffective because it cannot remove the causative material. 2)

Control inflammation and intraocular pressure as much as possible before surgery.

Intraocular pressure reduction (for hypermature cataract or high IOP cases): 2)

  • Osmotic diuretics (intravenous mannitol)
  • Carbonic anhydrase inhibitors (oral acetazolamide)

Preoperative anti-inflammatory therapy (for phacogenic types): 1)

  • Prednisolone 1% eye drops (every 6 hours)
  • Nepafenac 0.1% eye drops (every 8 hours)
  • Prednisone 40 mg orally
  • Celecoxib 200 mg orally

Phacoemulsification (PEA)

Indications: Cases with an intact or partially damaged capsule and a soft to moderately hard nucleus.

Features: Simultaneous IOL insertion (in-the-bag or sulcus fixation). If retrolental opacity is present, anterior vitrectomy is combined. 1)

Postoperative outcomes: Reports have achieved corrected visual acuity of 20/25 at 2 months postoperatively. 1)

Extracapsular Cataract Extraction (ECCE/MSICS)

Indications: Hypermature/hard nuclear cataracts (Morgagnian cataract). 2)

Features: Manual extracapsular extraction using iris hooks and trypan blue staining. Safety of MSICS surgery has been reported. 2)

Postoperative outcomes: Reports have achieved corrected visual acuity of 20/40 at 1 month postoperatively. 2)

Phacoanaphylactic Glaucoma

Definition (EGS 5th edition): Secondary glaucoma associated with granulomatous inflammation to lens proteins. 3)

Treatment strategy: Trabeculectomy alone is ineffective. Lens extraction is essential. Perform cataract surgery after preoperative management with intraocular pressure-lowering medications. 2, 3)

The lens is an organ that acquired immune privilege during embryonic development. 2) Lens proteins (α, β, γ crystallins) are sequestered early in development, so they are not registered in the T-cell repertoire and are treated as “non-self” proteins. Normally, the lens capsule contains these proteins and prevents contact with the immune system.

Capsular Rupture Type (Type IV, Delayed Hypersensitivity) 1)

Section titled “Capsular Rupture Type (Type IV, Delayed Hypersensitivity) 1)”

When the capsule is physically damaged, lens proteins are massively exposed into the anterior chamber. Sensitized T cells are activated, leading to a CD4-positive helper T cell-driven type IV (delayed) hypersensitivity reaction. Pathologically, zonal granuloma is characteristic, with multinucleated giant cells, epithelioid cells, and lymphocytes accumulating around the lens proteins. 2)

In hypermature cataracts, liquefaction of the nucleus leads to leakage of high-molecular-weight proteins such as α-crystallin through microscopic pores in the capsule. Engorged macrophages physically obstruct the trabecular meshwork, resulting in secondary open-angle glaucoma.

It is reported that more than 50% of LIU cases are complicated by secondary glaucoma (phacoanaphylactic glaucoma). 3) The 5th edition of the EGS Glaucoma Guidelines defines this as an independent disease entity. 3)


7. Latest Research and Future Perspectives (Investigational Reports)

Section titled “7. Latest Research and Future Perspectives (Investigational Reports)”

Preoperative evaluation of the capsule using ultrasound biomicroscopy (UBM) contributes to improved diagnostic accuracy.

Lopez-Zuniga et al. (2025) reported a case of LIU in a 76-year-old male where UBM confirmed an intact capsule, leading to a diagnosis of phacolytic type. This allowed appropriate planning of the surgical approach. 1)

UBM enables preoperative assessment of capsular rupture and aids in the choice between extracapsular cataract extraction and phacoemulsification. Future improvements in noninvasive preoperative diagnostic accuracy are expected through combination with OCT.

Conventionally, LIU was often considered an anterior segment disease, but inflammatory spread to the vitreous cavity (retrolental opacity) has come to be recognized.

Lopez-Zuniga et al. (2025) showed that performing anterior vitrectomy simultaneously with PEA + IOL insertion can achieve good postoperative visual acuity (20/25 at 2 months postoperatively) even in cases with retrolental opacity. 1)

Healthcare Access Issues and Management of Hypermature Cataract

Section titled “Healthcare Access Issues and Management of Hypermature Cataract”

In developing countries and rural areas, neglected cataracts lead to an increase in hypermature cataracts, and the incidence of LIU remains high. 2)

Bievel-Radulescu et al. (2021) reported the case of an 83-year-old farmer with limited healthcare access, highlighting the challenges of late-stage cataract management in rural areas. 2)

Cataract outreach programs and mobile ophthalmic surgical teams are gaining attention as preventive interventions.


  1. Lopez-Zuniga DI, Ruiz-Lozano RE, Garza-Garza LA, et al. Phacoanaphylactic endophthalmitis: a case report and review of the literature. Cureus. 2025;17(9):e93053.
  2. Bievel-Radulescu R, Tiu C, Tiu VE, et al. Phacoanaphylactic endophthalmitis with secondary glaucoma in a patient with hypermature cataract. Rom J Ophthalmol. 2021;65(3):300-306.
  3. European Glaucoma Society. Terminology and Guidelines for Glaucoma, 5th Edition. Br J Ophthalmol. 2021;105(Suppl 1):1-169.

Copy the article text and paste it into your preferred AI assistant.